First Mercantile Trust’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $94K | Buy |
2,830
+63
| +2% | +$2.09K | 0.01% | 670 |
|
|
2021
Q2 | $107K | Buy |
2,767
+801
| +41% | +$31K | 0.01% | 663 |
|
|
2021
Q1 | $95K | Sell |
1,966
-1,856
| -49% | -$89.7K | 0.01% | 693 |
|
|
2020
Q4 | $199K | Sell |
3,822
-1,015
| -21% | -$52.8K | 0.02% | 422 |
|
|
2020
Q3 | $140K | Buy |
+4,837
| New | +$140K | 0.02% | 555 |
|
|
2019
Q1 | – | Sell |
-12,858
| Closed | -$53K | – | 922 |
|
|
2018
Q4 | $53K | Sell |
12,858
-698
| -5% | -$2.88K | 0.01% | 765 |
|
|
2018
Q3 | $76K | Sell |
13,556
-6,667
| -33% | -$37.4K | 0.01% | 752 |
|
|
2018
Q2 | $266K | Sell |
20,223
-5,443
| -21% | -$71.6K | 0.05% | 414 |
|
|
2018
Q1 | $364K | Sell |
25,666
-1,035
| -4% | -$14.7K | 0.08% | 321 |
|
|
2017
Q4 | $219K | Buy |
26,701
+5,938
| +29% | +$48.7K | 0.04% | 511 |
|
|
2017
Q3 | $246K | Buy |
20,763
+1,584
| +8% | +$18.8K | 0.04% | 510 |
|
|
2017
Q2 | $193K | Buy |
19,179
+12,779
| +200% | +$129K | 0.03% | 578 |
|
|
2017
Q1 | $75K | Buy |
+6,400
| New | +$75K | 0.01% | 768 |
|